Myomo (MYO) Current Leases (2020 - 2025)

Myomo (MYO) posted Current Leases of $494662.0 for Q4 2025, up 6.55% on a QoQ basis from $464239.0 in Q3 2025, and down 33.87% year-over-year from $748021.0 in Q4 2024.

Myomo (MYO) Current Leases (2020 - 2025) Analysis & Trends

Myomo's Current Leases history runs 6 years deep, the most recent figure standing at $494662.0 for Q4 2025.

  • Quarterly Current Leases fell 33.87% year-over-year to $494662.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $494662.0 (down 33.87% YoY) and the FY2025 annual result came in at $494662.0, down 33.87% from the prior year.
  • Current Leases was $494662.0 for Q4 2025 at Myomo, up from $464239.0 in the prior quarter.
  • Across five years, Current Leases topped out at $765616.0 in Q1 2025 and bottomed at $181783.0 in Q2 2023.
  • A 5-year average of $403855.2 and a median of $416005.5 in 2022 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2021 — Current Leases jumped 1722.84% — and 2023, when it sank 58.37%.
  • Myomo's Current Leases stood at $333380.0 in 2021, then gained by 6.1% to $353701.0 in 2022, then surged by 37.44% to $486143.0 in 2023, then jumped by 53.87% to $748021.0 in 2024, then slumped by 33.87% to $494662.0 in 2025.
  • Business Quant data shows MYO's Current Leases at $494662.0 in Q4 2025, $464239.0 in Q3 2025, and $460351.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Myomo 39.24 Mn 20.27 Mn - 494,662.00

Historic Data

Download Data
DateValue
Dec 31, 2025 494,662.00
Sep 30, 2025 464,239.00
Jun 30, 2025 460,351.00
Mar 31, 2025 765,616.00
Dec 31, 2024 748,021.00
Sep 30, 2024 205,464.00
Jun 30, 2024 316,600.00
Mar 31, 2024 421,514.00
Dec 31, 2023 486,143.00
Sep 30, 2023 456,064.00
Jun 30, 2023 181,783.00
Mar 31, 2023 275,028.00
Dec 31, 2022 353,701.00
Sep 30, 2022 441,386.00
Jun 30, 2022 436,694.00
Mar 31, 2022 410,497.00
Dec 31, 2021 333,380.00
Sep 30, 2021 301,878.00
Jun 30, 2021 319,624.00
Mar 31, 2021 204,460.00